Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-8.12M -13.89M -7.43M -6.54M -7.53M
Depreciation & Amortization
207.11K n/a 178.11K 135.36K 101.8K
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
-5.32M -4.18M 108.54M -93.53K -510.19K
Other Non-Cash Items
837.18K 18.07M 276.77K 103.79K 95.66K
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-4.05M -4.18M -9.63M -454.23K -412.85K
Operating Cash Flow
-10.21M n/a -15.74M -6.15M -4.85M
Capital Expenditures
-1.09M n/a 2.26M -3.28M -363.4K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
-109.81K n/a -5.46M -23M -38.2M
Sales Maturities Of Investments
18M n/a 5.32M 22.88M 38M
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
16.8M n/a 2.12M -3.41M -567.26K
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
-55.19K n/a -61.16K -30.17K 25.64M
Financial Cash Flow
-55.19K n/a -61.16K -30.17K 25.64M
Net Cash Flow
6.53M n/a -13.68M -9.59M 20.22M
Free Cash Flow
-11.31M n/a -13.47M -9.44M -5.21M